Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 128

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 128
---
 we incorporate by reference, contain forward-looking statements within the meaning of the federal securities
laws. You should not rely on forward-looking statements in this prospectus, and the documents we incorporate by reference. Forward-looking
statements typically are identified by use of terms such as “anticipate,” “believe,” “plan,” “expect,”
“future,” “intend,” “may,” “will,” “should,” “estimate,” “predict,”
“potential,” “continue,” and similar words, although some forward-looking statements are expressed differently.
This prospectus, and the documents we incorporate by reference, may also contain forward-looking statements attributed to third parties
relating to their estimates regarding the markets we may enter in the future. All forward-looking statements address matters that involve
risk and uncertainties, and there are many important risks, uncertainties and other factors that could cause our actual results to differ
materially from the forward-looking statements contained in this prospectus, and the documents we incorporate by reference.

You should also carefully consider
the statements under “ Risk Factors” and other sections of this prospectus, which address additional facts that
could cause our actual results to differ from those set forth in the forward-looking statements. We caution investors not to place significant
reliance on the forward-looking statements contained in this prospectus, and the documents we incorporate by reference. We undertake no
obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or
otherwise.

<div align='center'>69

THE COMMITTED EQUITY FACILITY</div>

On July 28, 2025, we entered
into the Purchase Agreement and the ELOC Registration Rights Agreement with Ascent. Upon the terms and subject to the satisfaction of
the conditions contained in the Purchase Agreement, from and after the Effective Date, we will have the right, in our sole discretion,
to sell to Ascent up to $100,000,000 of shares of our Common Stock, subject to certain limitations set forth in the Purchase Agreement,
from time to time after the date of this prospectus and during the term of the Purchase Agreement. Sales of Common Stock by us to Ascent
under the Purchase Agreement, and the timing of any such sales, are solely at our option, and we are under no obligation to sell any securities
to Ascent under the Purchase Agreement. In accordance with our obligations under the ELOC Registration Rights Agreement, we previously
filed a registration statement, declared effective